Patent ID: 8956655
Filing Date: 2015-02-17
Classification: A61F,A61K,A61P,C07K

Abstract:
1. A drug delivery system for treating an ocular condition, the drug delivery system comprising a bioerodible implant, said implant comprising a plurality of segments, wherein: a) each of the segments comprises (i) an active agent and (ii) a bioerodible polymer; b) at least one of the segments has drug release characteristics different from the other segments; c) each of the segments has a (i) a longitudinal axis; and (ii) at least one end having a cut surface that is at an angle to the longitudinal axis of less than 90°, or having at least one end which is of beveled shape; and d) the segments are joined together in a manner to permit separation of the segments from each other in situ into individual segments following intraocular implantation of the drug delivery system into a patient.